ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	14/159	30/7206	3.90847991403e-16
ko04612	Antigen processing and presentation	18/159	77/7206	3.11562048559e-14
ko04060	Cytokine-cytokine receptor interaction	25/159	191/7206	3.55370191972e-13
ko05320	Autoimmune thyroid disease	11/159	29/7206	1.04868448271e-11
ko05330	Allograft rejection	10/159	24/7206	3.09973680254e-11
ko05168	Herpes simplex infection	22/159	182/7206	5.26484935963e-11
ko05164	Influenza A	21/159	167/7206	7.04838921124e-11
ko05152	Tuberculosis	22/159	187/7206	9.03099343394e-11
ko05332	Graft-versus-host disease	8/159	18/7206	1.70982625957e-09
ko04672	Intestinal immune network for IgA production	10/159	37/7206	4.30106288395e-09
ko05162	Measles	16/159	120/7206	6.35858801654e-09
ko04621	NOD-like receptor signaling pathway	18/159	157/7206	8.00626966386e-09
ko04640	Hematopoietic cell lineage	12/159	64/7206	1.07135138679e-08
ko05145	Toxoplasmosis	16/159	126/7206	1.30452612286e-08
ko05321	Inflammatory bowel disease (IBD)	11/159	56/7206	2.70011635291e-08
ko04620	Toll-like receptor signaling pathway	14/159	100/7206	3.13359945237e-08
ko04217	Necroptosis	18/159	178/7206	5.82925410199e-08
ko04659	Th17 cell differentiation	14/159	106/7206	6.68674217208e-08
ko05140	Leishmaniasis	12/159	75/7206	6.91105819085e-08
ko04940	Type I diabetes mellitus	8/159	32/7206	3.15952105418e-07
ko05310	Asthma	6/159	17/7206	1.06304912838e-06
ko04064	NF-kappa B signaling pathway	12/159	96/7206	1.10781404279e-06
ko04658	Th1 and Th2 cell differentiation	11/159	96/7206	7.47570201956e-06
ko04650	Natural killer cell mediated cytotoxicity	11/159	97/7206	8.27324494469e-06
ko05150	Staphylococcus aureus infection	7/159	36/7206	1.08731191742e-05
ko04145	Phagosome	14/159	162/7206	1.20005593242e-05
ko05133	Pertussis	10/159	87/7206	1.91470532148e-05
ko03050	Proteasome	8/159	54/7206	2.06947591565e-05
ko05416	Viral myocarditis	8/159	55/7206	2.37684513304e-05
ko05161	Hepatitis B	14/159	173/7206	2.5347267367e-05
ko04514	Cell adhesion molecules (CAMs)	12/159	130/7206	2.67572081473e-05
ko04062	Chemokine signaling pathway	15/159	201/7206	3.37097519584e-05
ko04380	Osteoclast differentiation	12/159	134/7206	3.62509855897e-05
ko04622	RIG-I-like receptor signaling pathway	8/159	62/7206	5.79071535208e-05
ko04660	T cell receptor signaling pathway	11/159	124/7206	8.42542401109e-05
ko05323	Rheumatoid arthritis	9/159	89/7206	0.00013896372784
ko04630	Jak-STAT signaling pathway	11/159	132/7206	0.000148164088572
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/159	191/7206	0.000287823863672
ko05144	Malaria	6/159	45/7206	0.000419679194526
ko04210	Apoptosis	11/159	180/7206	0.0020351448219
ko05142	Chagas disease (American trypanosomiasis)	9/159	130/7206	0.00223268335773
ko05146	Amoebiasis	7/159	99/7206	0.00608204677755
ko05166	HTLV-I infection	14/159	292/7206	0.00629382533106
ko05160	Hepatitis C	9/159	153/7206	0.00658002618595
ko04610	Complement and coagulation cascades	6/159	79/7206	0.00775036746507
ko04623	Cytosolic DNA-sensing pathway	4/159	41/7206	0.0122566959273
ko05322	Systemic lupus erythematosus	8/159	151/7206	0.0182935554047
ko04080	Neuroactive ligand-receptor interaction	3/159	423/7206	0.0254914510001
ko05143	African trypanosomiasis	3/159	32/7206	0.0327552840907
ko04668	TNF signaling pathway	6/159	120/7206	0.0491236390724
ko04142	Lysosome	7/159	151/7206	0.0491961091676